These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9743315)

  • 1. Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years.
    Bala MV; Wood LL; Zarkin GA; Norton EC; Gafni A; O'Brien B
    J Clin Epidemiol; 1998 Aug; 51(8):667-76. PubMed ID: 9743315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
    Franic DM; Pathak DS; Gafni A
    J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminishing willingness to pay per quality-adjusted life year: valuing acute foodborne illness.
    Haninger K; Hammitt JK
    Risk Anal; 2011 Sep; 31(9):1363-80. PubMed ID: 21488924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of social care for adults: developing a preference-weighted measure.
    Netten A; Burge P; Malley J; Potoglou D; Towers AM; Brazier J; Flynn T; Forder J; Wall B
    Health Technol Assess; 2012; 16(16):1-166. PubMed ID: 22459668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong.
    You JHS; Ming WK; Lee CF; Tsang OT; Chan PK
    Vaccine; 2018 Jul; 36(31):4610-4620. PubMed ID: 29958739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theory versus practice: a review of 'willingness-to-pay' in health and health care.
    Olsen JA; Smith RD
    Health Econ; 2001 Jan; 10(1):39-52. PubMed ID: 11180568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Hornberger J; Robertus K
    Ann Intern Med; 2006 Sep; 145(5):317-25. PubMed ID: 16954357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to pay for a QALY: theoretical and methodological issues.
    Gyrd-Hansen D
    Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing avoided morbidity using meta-regression analysis: what can health status measures and QALYs tell us about WTP?
    Van Houtven G; Powers J; Jessup A; Yang JC
    Health Econ; 2006 Aug; 15(8):775-95. PubMed ID: 16544361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QALYs versus WTP.
    Hammit JK
    Risk Anal; 2002 Oct; 22(5):985-1001. PubMed ID: 12442993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to pay and the valuation of programmes for the prevention and control of influenza.
    Birch S; Gafni A; O'Brien B
    Pharmacoeconomics; 1999; 16 Suppl 1():55-61. PubMed ID: 10623377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
    King JT; Tsevat J; Lave JR; Roberts MS
    Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of willingness to pay for hip and knee joint replacement surgery for osteoarthritis.
    Cross MJ; March LM; Lapsley HM; Tribe KL; Brnabic AJ; Courtenay BG; Brooks PM
    Rheumatology (Oxford); 2000 Nov; 39(11):1242-8. PubMed ID: 11085804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
    Byrne MM; O'malley K; Suarez-Almazor ME
    Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
    Nimdet K; Ngorsuraches S
    BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 3-Year Cost-Effectiveness of a Nurse-Based Case Management versus Usual Care for Elderly Patients with Myocardial Infarction: Results from the KORINNA Follow-Up Study.
    Seidl H; Hunger M; Meisinger C; Kirchberger I; Kuch B; Leidl R; Holle R
    Value Health; 2017 Mar; 20(3):441-450. PubMed ID: 28292489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.